nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ABCB1—peripheral nervous system neoplasm	0.228	1	CbGaD
Prazosin—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.171	0.298	CbGbCtD
Prazosin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0517	0.0901	CbGbCtD
Prazosin—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0505	0.088	CbGbCtD
Prazosin—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0443	0.0773	CbGbCtD
Prazosin—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0381	0.0665	CbGbCtD
Prazosin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0358	0.0625	CbGbCtD
Prazosin—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0279	0.0486	CbGbCtD
Prazosin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0221	0.0385	CbGbCtD
Prazosin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0206	0.0359	CbGbCtD
Prazosin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0202	0.0352	CbGbCtD
Prazosin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0186	0.0325	CbGbCtD
Prazosin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0186	0.0325	CbGbCtD
Prazosin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0138	0.024	CbGbCtD
Prazosin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0129	0.0225	CbGbCtD
Prazosin—HTR1D—meninx—peripheral nervous system neoplasm	0.0103	0.175	CbGeAlD
Prazosin—HTR1D—dura mater—peripheral nervous system neoplasm	0.00944	0.161	CbGeAlD
Prazosin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00795	0.0139	CbGbCtD
Prazosin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00742	0.0129	CbGbCtD
Prazosin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00729	0.0127	CbGbCtD
Prazosin—MT3—nerve—peripheral nervous system neoplasm	0.00502	0.0858	CbGeAlD
Prazosin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00497	0.00867	CbGbCtD
Prazosin—MT3—ganglion—peripheral nervous system neoplasm	0.00496	0.0848	CbGeAlD
Prazosin—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00406	0.0694	CbGeAlD
Prazosin—KCNH6—ganglion—peripheral nervous system neoplasm	0.00354	0.0604	CbGeAlD
Prazosin—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00289	0.0494	CbGeAlD
Prazosin—MT3—brainstem—peripheral nervous system neoplasm	0.00216	0.0368	CbGeAlD
Prazosin—SLC22A1—ganglion—peripheral nervous system neoplasm	0.00148	0.0252	CbGeAlD
Prazosin—HTR1D—ganglion—peripheral nervous system neoplasm	0.00146	0.025	CbGeAlD
Prazosin—SLC22A3—tongue—peripheral nervous system neoplasm	0.0014	0.0239	CbGeAlD
Prazosin—HTR1A—ganglion—peripheral nervous system neoplasm	0.00122	0.0208	CbGeAlD
Prazosin—KCNH7—cerebellum—peripheral nervous system neoplasm	0.00106	0.0182	CbGeAlD
Prazosin—MT3—cerebellum—peripheral nervous system neoplasm	0.00106	0.0182	CbGeAlD
Prazosin—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.00103	0.0176	CbGeAlD
Prazosin—Terazosin—ABCB1—peripheral nervous system neoplasm	0.000989	0.573	CrCbGaD
Prazosin—Doxazosin—ABCB1—peripheral nervous system neoplasm	0.000736	0.427	CrCbGaD
Prazosin—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.000719	0.0123	CbGeAlD
Prazosin—SLC22A3—trigeminal ganglion—peripheral nervous system neoplasm	0.000694	0.0119	CbGeAlD
Prazosin—SLC22A3—parotid gland—peripheral nervous system neoplasm	0.000654	0.0112	CbGeAlD
Prazosin—HTR1D—brainstem—peripheral nervous system neoplasm	0.000636	0.0109	CbGeAlD
Prazosin—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000534	0.00912	CbGeAlD
Prazosin—HTR1A—brainstem—peripheral nervous system neoplasm	0.00053	0.00906	CbGeAlD
Prazosin—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000489	0.00835	CbGeAlD
Prazosin—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000475	0.00811	CbGeAlD
Prazosin—ABCG2—parotid gland—peripheral nervous system neoplasm	0.000448	0.00765	CbGeAlD
Prazosin—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000425	0.00726	CbGeAlD
Prazosin—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00042	0.00718	CbGeAlD
Prazosin—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.00285	CcSEcCtD
Prazosin—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00284	CcSEcCtD
Prazosin—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000288	0.0028	CcSEcCtD
Prazosin—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000288	0.0028	CcSEcCtD
Prazosin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000287	0.00279	CcSEcCtD
Prazosin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000285	0.00277	CcSEcCtD
Prazosin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000285	0.00277	CcSEcCtD
Prazosin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000285	0.00277	CcSEcCtD
Prazosin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.00275	CcSEcCtD
Prazosin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000283	0.00275	CcSEcCtD
Prazosin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000283	0.00275	CcSEcCtD
Prazosin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000281	0.00273	CcSEcCtD
Prazosin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.00272	CcSEcCtD
Prazosin—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00269	CcSEcCtD
Prazosin—Flushing—Etoposide—peripheral nervous system neoplasm	0.000277	0.00269	CcSEcCtD
Prazosin—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.00264	CcSEcCtD
Prazosin—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000268	0.0026	CcSEcCtD
Prazosin—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000267	0.0026	CcSEcCtD
Prazosin—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.0026	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000267	0.00259	CcSEcCtD
Prazosin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000266	0.00259	CcSEcCtD
Prazosin—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.00257	CcSEcCtD
Prazosin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000264	0.00256	CcSEcCtD
Prazosin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000264	0.00256	CcSEcCtD
Prazosin—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000264	0.00256	CcSEcCtD
Prazosin—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00256	CcSEcCtD
Prazosin—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00255	CcSEcCtD
Prazosin—Oedema—Vincristine—peripheral nervous system neoplasm	0.000262	0.00254	CcSEcCtD
Prazosin—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000262	0.00447	CbGeAlD
Prazosin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00026	0.00253	CcSEcCtD
Prazosin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000259	0.00252	CcSEcCtD
Prazosin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.0025	CcSEcCtD
Prazosin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000257	0.0025	CcSEcCtD
Prazosin—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000256	0.00248	CcSEcCtD
Prazosin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000255	0.00248	CcSEcCtD
Prazosin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000254	0.00247	CcSEcCtD
Prazosin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000253	0.00246	CcSEcCtD
Prazosin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000253	0.00246	CcSEcCtD
Prazosin—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000253	0.00246	CcSEcCtD
Prazosin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000252	0.00245	CcSEcCtD
Prazosin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00025	0.00243	CcSEcCtD
Prazosin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00025	0.00243	CcSEcCtD
Prazosin—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.00241	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.0024	CcSEcCtD
Prazosin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000247	0.0024	CcSEcCtD
Prazosin—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00239	CcSEcCtD
Prazosin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000245	0.00238	CcSEcCtD
Prazosin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000245	0.00238	CcSEcCtD
Prazosin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.00237	CcSEcCtD
Prazosin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.00235	CcSEcCtD
Prazosin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000242	0.00235	CcSEcCtD
Prazosin—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.00235	CcSEcCtD
Prazosin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000241	0.00234	CcSEcCtD
Prazosin—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000241	0.00412	CbGeAlD
Prazosin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000241	0.00234	CcSEcCtD
Prazosin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000239	0.00232	CcSEcCtD
Prazosin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000238	0.00232	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000238	0.00232	CcSEcCtD
Prazosin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000237	0.0023	CcSEcCtD
Prazosin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000237	0.0023	CcSEcCtD
Prazosin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000237	0.0023	CcSEcCtD
Prazosin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000235	0.00228	CcSEcCtD
Prazosin—Malaise—Etoposide—peripheral nervous system neoplasm	0.000234	0.00228	CcSEcCtD
Prazosin—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000234	0.004	CbGeAlD
Prazosin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000234	0.00227	CcSEcCtD
Prazosin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000233	0.00227	CcSEcCtD
Prazosin—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000233	0.00398	CbGeAlD
Prazosin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00226	CcSEcCtD
Prazosin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00226	CcSEcCtD
Prazosin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000231	0.00225	CcSEcCtD
Prazosin—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000231	0.00225	CcSEcCtD
Prazosin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00023	0.00223	CcSEcCtD
Prazosin—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000228	0.00222	CcSEcCtD
Prazosin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000228	0.00221	CcSEcCtD
Prazosin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000228	0.00221	CcSEcCtD
Prazosin—Rash—Topotecan—peripheral nervous system neoplasm	0.000228	0.00221	CcSEcCtD
Prazosin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000227	0.00221	CcSEcCtD
Prazosin—Headache—Topotecan—peripheral nervous system neoplasm	0.000226	0.0022	CcSEcCtD
Prazosin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000226	0.00219	CcSEcCtD
Prazosin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000226	0.00219	CcSEcCtD
Prazosin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000226	0.00219	CcSEcCtD
Prazosin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000226	0.00219	CcSEcCtD
Prazosin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000226	0.00219	CcSEcCtD
Prazosin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000226	0.00219	CcSEcCtD
Prazosin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000225	0.00218	CcSEcCtD
Prazosin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000224	0.00218	CcSEcCtD
Prazosin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000224	0.00218	CcSEcCtD
Prazosin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.00217	CcSEcCtD
Prazosin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000224	0.00217	CcSEcCtD
Prazosin—Pain—Vincristine—peripheral nervous system neoplasm	0.000224	0.00217	CcSEcCtD
Prazosin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00217	CcSEcCtD
Prazosin—Rash—Melphalan—peripheral nervous system neoplasm	0.000223	0.00217	CcSEcCtD
Prazosin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000223	0.00216	CcSEcCtD
Prazosin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000221	0.00214	CcSEcCtD
Prazosin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000218	0.00212	CcSEcCtD
Prazosin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000216	0.0021	CcSEcCtD
Prazosin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.0021	CcSEcCtD
Prazosin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.00209	CcSEcCtD
Prazosin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000214	0.00208	CcSEcCtD
Prazosin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000213	0.00207	CcSEcCtD
Prazosin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000213	0.00207	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000211	0.00205	CcSEcCtD
Prazosin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00021	0.00204	CcSEcCtD
Prazosin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00021	0.00204	CcSEcCtD
Prazosin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000208	0.00202	CcSEcCtD
Prazosin—ABCG2—cerebellum—peripheral nervous system neoplasm	0.000207	0.00354	CbGeAlD
Prazosin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000207	0.00201	CcSEcCtD
Prazosin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000207	0.00201	CcSEcCtD
Prazosin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000206	0.002	CcSEcCtD
Prazosin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000205	0.00199	CcSEcCtD
Prazosin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00199	CcSEcCtD
Prazosin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00198	CcSEcCtD
Prazosin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00198	CcSEcCtD
Prazosin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.00195	CcSEcCtD
Prazosin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.00194	CcSEcCtD
Prazosin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000198	0.00192	CcSEcCtD
Prazosin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00189	CcSEcCtD
Prazosin—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00188	CcSEcCtD
Prazosin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000193	0.00187	CcSEcCtD
Prazosin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00187	CcSEcCtD
Prazosin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000191	0.00185	CcSEcCtD
Prazosin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00019	0.00185	CcSEcCtD
Prazosin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00184	CcSEcCtD
Prazosin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000189	0.00184	CcSEcCtD
Prazosin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000188	0.00183	CcSEcCtD
Prazosin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00183	CcSEcCtD
Prazosin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000188	0.00182	CcSEcCtD
Prazosin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00181	CcSEcCtD
Prazosin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.00181	CcSEcCtD
Prazosin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.0018	CcSEcCtD
Prazosin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000185	0.00179	CcSEcCtD
Prazosin—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000183	0.00313	CbGeAlD
Prazosin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00178	CcSEcCtD
Prazosin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000183	0.00178	CcSEcCtD
Prazosin—Pain—Etoposide—peripheral nervous system neoplasm	0.000181	0.00176	CcSEcCtD
Prazosin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000181	0.00176	CcSEcCtD
Prazosin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.00174	CcSEcCtD
Prazosin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000179	0.00174	CcSEcCtD
Prazosin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00173	CcSEcCtD
Prazosin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00171	CcSEcCtD
Prazosin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000175	0.0017	CcSEcCtD
Prazosin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.00169	CcSEcCtD
Prazosin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000173	0.00168	CcSEcCtD
Prazosin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.00168	CcSEcCtD
Prazosin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00167	CcSEcCtD
Prazosin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.00166	CcSEcCtD
Prazosin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.00166	CcSEcCtD
Prazosin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00017	0.00166	CcSEcCtD
Prazosin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00165	CcSEcCtD
Prazosin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.00165	CcSEcCtD
Prazosin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000168	0.00164	CcSEcCtD
Prazosin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000168	0.00163	CcSEcCtD
Prazosin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000166	0.00162	CcSEcCtD
Prazosin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000166	0.00161	CcSEcCtD
Prazosin—Rash—Vincristine—peripheral nervous system neoplasm	0.000165	0.0016	CcSEcCtD
Prazosin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000165	0.0016	CcSEcCtD
Prazosin—Headache—Vincristine—peripheral nervous system neoplasm	0.000164	0.00159	CcSEcCtD
Prazosin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00158	CcSEcCtD
Prazosin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.00157	CcSEcCtD
Prazosin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000158	0.00154	CcSEcCtD
Prazosin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00153	CcSEcCtD
Prazosin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000156	0.00152	CcSEcCtD
Prazosin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00151	CcSEcCtD
Prazosin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000155	0.00151	CcSEcCtD
Prazosin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00151	CcSEcCtD
Prazosin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000152	0.00148	CcSEcCtD
Prazosin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00015	0.00146	CcSEcCtD
Prazosin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00144	CcSEcCtD
Prazosin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000147	0.00143	CcSEcCtD
Prazosin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000146	0.00142	CcSEcCtD
Prazosin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000146	0.00142	CcSEcCtD
Prazosin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000145	0.00141	CcSEcCtD
Prazosin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.0014	CcSEcCtD
Prazosin—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.0014	CcSEcCtD
Prazosin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00139	CcSEcCtD
Prazosin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00137	CcSEcCtD
Prazosin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00014	0.00136	CcSEcCtD
Prazosin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000137	0.00134	CcSEcCtD
Prazosin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00133	CcSEcCtD
Prazosin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00133	CcSEcCtD
Prazosin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00131	CcSEcCtD
Prazosin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000135	0.00131	CcSEcCtD
Prazosin—Rash—Etoposide—peripheral nervous system neoplasm	0.000134	0.0013	CcSEcCtD
Prazosin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000133	0.0013	CcSEcCtD
Prazosin—Headache—Etoposide—peripheral nervous system neoplasm	0.000133	0.00129	CcSEcCtD
Prazosin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00128	CcSEcCtD
Prazosin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00128	CcSEcCtD
Prazosin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00127	CcSEcCtD
Prazosin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00127	CcSEcCtD
Prazosin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00127	CcSEcCtD
Prazosin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00125	CcSEcCtD
Prazosin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00124	CcSEcCtD
Prazosin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00123	CcSEcCtD
Prazosin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000126	0.00122	CcSEcCtD
Prazosin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00121	CcSEcCtD
Prazosin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.0012	CcSEcCtD
Prazosin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00119	CcSEcCtD
Prazosin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00118	CcSEcCtD
Prazosin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00118	CcSEcCtD
Prazosin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00118	CcSEcCtD
Prazosin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00117	CcSEcCtD
Prazosin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00116	CcSEcCtD
Prazosin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00115	CcSEcCtD
Prazosin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00115	CcSEcCtD
Prazosin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00114	CcSEcCtD
Prazosin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00113	CcSEcCtD
Prazosin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00112	CcSEcCtD
Prazosin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00111	CcSEcCtD
Prazosin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.0011	CcSEcCtD
Prazosin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00109	CcSEcCtD
Prazosin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00107	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000108	0.00105	CcSEcCtD
Prazosin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00105	CcSEcCtD
Prazosin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00104	CcSEcCtD
Prazosin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00104	CcSEcCtD
Prazosin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00104	CcSEcCtD
Prazosin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00103	CcSEcCtD
Prazosin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.00103	CcSEcCtD
Prazosin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000106	0.00103	CcSEcCtD
Prazosin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000995	CcSEcCtD
Prazosin—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000102	0.00175	CbGeAlD
Prazosin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000987	CcSEcCtD
Prazosin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000987	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000973	CcSEcCtD
Prazosin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.000966	CcSEcCtD
Prazosin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.87e-05	0.000959	CcSEcCtD
Prazosin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000952	CcSEcCtD
Prazosin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.79e-05	0.000951	CcSEcCtD
Prazosin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000949	CcSEcCtD
Prazosin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000921	CcSEcCtD
Prazosin—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.44e-05	0.000917	CcSEcCtD
Prazosin—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000913	CcSEcCtD
Prazosin—Pain—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000913	CcSEcCtD
Prazosin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000912	CcSEcCtD
Prazosin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.00088	CcSEcCtD
Prazosin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.00085	CcSEcCtD
Prazosin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.73e-05	0.000848	CcSEcCtD
Prazosin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000844	CcSEcCtD
Prazosin—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000828	CcSEcCtD
Prazosin—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.4e-05	0.000817	CcSEcCtD
Prazosin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.00079	CcSEcCtD
Prazosin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000787	CcSEcCtD
Prazosin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000766	CcSEcCtD
Prazosin—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.000763	CcSEcCtD
Prazosin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000756	CcSEcCtD
Prazosin—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.55e-05	0.000734	CcSEcCtD
Prazosin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000731	CcSEcCtD
Prazosin—Rash—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000728	CcSEcCtD
Prazosin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000727	CcSEcCtD
Prazosin—Headache—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000723	CcSEcCtD
Prazosin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000706	CcSEcCtD
Prazosin—Nausea—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000686	CcSEcCtD
Prazosin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000679	CcSEcCtD
Prazosin—Rash—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000673	CcSEcCtD
Prazosin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000673	CcSEcCtD
Prazosin—Headache—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000669	CcSEcCtD
Prazosin—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000634	CcSEcCtD
Prazosin—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.31e-05	0.000656	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.31e-05	0.000656	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.3e-05	0.000653	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	2.27e-05	0.000645	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.27e-05	0.000644	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—TH—peripheral nervous system neoplasm	2.27e-05	0.000644	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.27e-05	0.000644	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	2.26e-05	0.000642	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.26e-05	0.000641	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	2.24e-05	0.000635	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.23e-05	0.000634	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.21e-05	0.000629	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.17e-05	0.000615	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.16e-05	0.000613	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	2.15e-05	0.000612	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.15e-05	0.000612	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	2.15e-05	0.000611	CbGpPWpGaD
Prazosin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.15e-05	0.000611	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.1e-05	0.000596	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.09e-05	0.000592	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.08e-05	0.00059	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.07e-05	0.000588	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	2.02e-05	0.000574	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	2.02e-05	0.000573	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.01e-05	0.000572	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2e-05	0.000568	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.99e-05	0.000566	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000562	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.96e-05	0.000555	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.95e-05	0.000554	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.95e-05	0.000553	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.94e-05	0.00055	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.9e-05	0.000538	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.89e-05	0.000536	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.88e-05	0.000535	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.88e-05	0.000534	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.87e-05	0.000532	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.87e-05	0.000531	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.86e-05	0.000529	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	1.85e-05	0.000525	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.84e-05	0.000522	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.82e-05	0.000516	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.82e-05	0.000516	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.81e-05	0.000513	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.8e-05	0.000511	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.8e-05	0.000511	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.79e-05	0.000509	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.79e-05	0.000508	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.76e-05	0.000499	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.75e-05	0.000496	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.74e-05	0.000493	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000492	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.71e-05	0.000487	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.71e-05	0.000486	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.7e-05	0.000483	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.68e-05	0.000478	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.67e-05	0.000474	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.66e-05	0.000472	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.65e-05	0.00047	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.65e-05	0.000469	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.63e-05	0.000464	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.61e-05	0.000458	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.6e-05	0.000454	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.59e-05	0.000452	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.57e-05	0.000447	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.57e-05	0.000446	CbGpPWpGaD
Prazosin—ADRA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.56e-05	0.000443	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.55e-05	0.000439	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.54e-05	0.000437	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.54e-05	0.000437	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.53e-05	0.000434	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.51e-05	0.000429	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.5e-05	0.000425	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.5e-05	0.000425	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.49e-05	0.000423	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.48e-05	0.000421	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.48e-05	0.00042	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.48e-05	0.000419	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.47e-05	0.000417	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.46e-05	0.000414	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.44e-05	0.00041	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.44e-05	0.000408	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000406	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.43e-05	0.000405	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	1.42e-05	0.000404	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	1.41e-05	0.000401	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.41e-05	0.0004	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.41e-05	0.0004	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.4e-05	0.000397	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.36e-05	0.000388	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000384	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.35e-05	0.000384	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.34e-05	0.000382	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.33e-05	0.000377	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	1.33e-05	0.000376	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000374	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.31e-05	0.000373	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000371	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.3e-05	0.00037	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.3e-05	0.000369	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.28e-05	0.000363	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	1.25e-05	0.000354	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.24e-05	0.000353	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.22e-05	0.000348	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.22e-05	0.000346	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-05	0.000339	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.19e-05	0.000338	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.18e-05	0.000336	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.17e-05	0.000333	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.16e-05	0.00033	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.16e-05	0.000328	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.15e-05	0.000327	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.15e-05	0.000326	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000324	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.14e-05	0.000323	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	1.12e-05	0.000319	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000318	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.12e-05	0.000317	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.1e-05	0.000313	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.1e-05	0.000313	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.09e-05	0.00031	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.09e-05	0.000309	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000307	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.06e-05	0.000302	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.06e-05	0.000302	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.000301	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.03e-05	0.000294	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.03e-05	0.000291	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.01e-05	0.000287	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.01e-05	0.000287	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.87e-06	0.00028	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.78e-06	0.000278	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.76e-06	0.000277	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	9.73e-06	0.000276	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.71e-06	0.000276	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	9.53e-06	0.000271	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	9.45e-06	0.000268	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.44e-06	0.000268	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.29e-06	0.000264	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.25e-06	0.000263	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.2e-06	0.000261	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	9.17e-06	0.00026	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	9.11e-06	0.000259	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.09e-06	0.000258	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.02e-06	0.000256	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	9e-06	0.000255	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.99e-06	0.000255	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.77e-06	0.000249	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.36e-06	0.000237	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	8.26e-06	0.000235	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.25e-06	0.000234	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	8.05e-06	0.000228	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	7.94e-06	0.000225	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.92e-06	0.000225	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.88e-06	0.000224	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.79e-06	0.000221	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.78e-06	0.000221	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.77e-06	0.000221	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.67e-06	0.000218	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	7.23e-06	0.000205	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.18e-06	0.000204	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.15e-06	0.000203	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.02e-06	0.000199	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	6.91e-06	0.000196	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.9e-06	0.000196	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.78e-06	0.000192	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.77e-06	0.000192	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.58e-06	0.000187	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.57e-06	0.000187	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.52e-06	0.000185	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.46e-06	0.000183	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.34e-06	0.00018	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.15e-06	0.000175	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	6.11e-06	0.000173	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.98e-06	0.00017	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.84e-06	0.000166	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.79e-06	0.000164	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.74e-06	0.000163	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.63e-06	0.00016	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.58e-06	0.000158	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.55e-06	0.000158	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.47e-06	0.000155	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.42e-06	0.000154	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.36e-06	0.000152	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.33e-06	0.000151	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.23e-06	0.000148	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.12e-06	0.000145	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.1e-06	0.000145	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.09e-06	0.000145	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.09e-06	0.000144	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.05e-06	0.000143	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.04e-06	0.000143	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	5e-06	0.000142	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.91e-06	0.000139	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.86e-06	0.000138	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.81e-06	0.000136	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.68e-06	0.000133	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.68e-06	0.000133	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.63e-06	0.000131	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.62e-06	0.000131	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.53e-06	0.000129	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.46e-06	0.000127	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.36e-06	0.000124	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.27e-06	0.000121	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.25e-06	0.000121	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.22e-06	0.00012	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.21e-06	0.00012	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.18e-06	0.000119	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.15e-06	0.000118	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.11e-06	0.000117	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.08e-06	0.000116	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4e-06	0.000114	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.97e-06	0.000113	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.93e-06	0.000112	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.88e-06	0.00011	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.86e-06	0.00011	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.82e-06	0.000109	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.8e-06	0.000108	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.77e-06	0.000107	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.62e-06	0.000103	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.58e-06	0.000102	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.53e-06	0.0001	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.5e-06	9.95e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.45e-06	9.79e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.42e-06	9.72e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.23e-06	9.17e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.21e-06	9.12e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.2e-06	9.1e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	3.17e-06	8.99e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.13e-06	8.9e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.12e-06	8.85e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.09e-06	8.77e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.02e-06	8.58e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.98e-06	8.47e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.98e-06	8.47e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.97e-06	8.43e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.92e-06	8.29e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.84e-06	8.06e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.73e-06	7.74e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.64e-06	7.49e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.63e-06	7.48e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.52e-06	7.16e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.51e-06	7.12e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-06	7.03e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.45e-06	6.96e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.34e-06	6.65e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.23e-06	6.32e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.14e-06	6.08e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.07e-06	5.88e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.71e-06	4.86e-05	CbGpPWpGaD
